APO Research

APO RESEARCH · REPORT

Over-The-Counter (OTC) Pet Medication

Selected research

Market Structure

Global Over-The-Counter (OTC) Pet Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Over-The-Counter (OTC) Pet Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Over-The-Counter (OTC) Pet Medication include Merck Animal Health, Elanco, Zoetis, Virbac, Vet's Best, Vetoquinol, Sentry, Purdue Pharma L.P. and PetIQ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Over-The-Counter (OTC) Pet Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Over-The-Counter (OTC) Pet Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Over-The-Counter (OTC) Pet Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Over-The-Counter (OTC) Pet Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Over-The-Counter (OTC) Pet Medication Segment by Company

Merck Animal Health

Elanco

Zoetis

Virbac

Vet's Best

Vetoquinol

Sentry

Purdue Pharma L.P.

PetIQ

Perrigo

Nutramax Laboratories

Mobedco-Vet

Ceva Santé Animale

Boehringer Ingelheim

Antelope Pets

Over-The-Counter (OTC) Pet Medication Segment by Type

Dogs

Cats

Others

Over-The-Counter (OTC) Pet Medication Segment by Application

Online Sales

Offline Sales

Over-The-Counter (OTC) Pet Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-The-Counter (OTC) Pet Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over-The-Counter (OTC) Pet Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-The-Counter (OTC) Pet Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Over-The-Counter (OTC) Pet Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Over-The-Counter (OTC) Pet Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Over-The-Counter (OTC) Pet Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Over-The-Counter (OTC) Pet Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Over-The-Counter (OTC) Pet Medication Industry Trends Table 2. Over-The-Counter (OTC) Pet Medication Industry Drivers Table 3. Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges Table 4. Over-The-Counter (OTC) Pet Medication Industry Restraints Table 5. Global Over-The-Counter (OTC) Pet Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Over-The-Counter (OTC) Pet Medication Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Manufacturers Table 9. Global Over-The-Counter (OTC) Pet Medication Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Over-The-Counter (OTC) Pet Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Over-The-Counter (OTC) Pet Medication Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Over-The-Counter (OTC) Pet Medication Manufacturers, Product Type & Application Table 13. Global Over-The-Counter (OTC) Pet Medication Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Over-The-Counter (OTC) Pet Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Dogs Table 17. Major Manufacturers of Cats Table 18. Major Manufacturers of Others Table 19. Global Over-The-Counter (OTC) Pet Medication Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021-2026) & (Kg) Table 21. Global Over-The-Counter (OTC) Pet Medication Sales by Type (2027-2032) & (Kg) Table 22. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2021-2026) Table 23. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2027-2032) Table 24. Global Over-The-Counter (OTC) Pet Medication Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2021-2026) & (Kg) Table 26. Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2027-2032) & (Kg) Table 27. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2021-2026) Table 28. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Online Sales Table 30. Major Manufacturers of Offline Sales Table 31. Global Over-The-Counter (OTC) Pet Medication Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021-2026) & (Kg) Table 33. Global Over-The-Counter (OTC) Pet Medication Sales by Application (2027-2032) & (Kg) Table 34. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2021-2026) Table 35. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2027-2032) Table 36. Global Over-The-Counter (OTC) Pet Medication Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 37. Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2021-2026) & (Kg) Table 38. Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2027-2032) & (Kg) Table 39. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2021-2026) Table 40. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2027-2032) Table 41. Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 42. Global Over-The-Counter (OTC) Pet Medication Sales by Region (2021-2026) & (Kg) Table 43. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Region (2021-2026) Table 44. Global Over-The-Counter (OTC) Pet Medication Sales Forecasted by Region (2027-2032) & (Kg) Table 45. Global Over-The-Counter (OTC) Pet Medication Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 47. North America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 48. North America Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 49. Europe Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 50. Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 51. Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 52. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 53. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 54. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 55. South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 57. South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 58. Global Over-The-Counter (OTC) Pet Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Over-The-Counter (OTC) Pet Medication Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Over-The-Counter (OTC) Pet Medication Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Region (2021-2026) Table 62. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Region (2027-2032) Table 63. Merck Animal Health Company Information Table 64. Merck Animal Health Business Overview Table 65. Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio Table 67. Merck Animal Health Recent Development Table 68. Elanco Company Information Table 69. Elanco Business Overview Table 70. Elanco Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio Table 72. Elanco Recent Development Table 73. Zoetis Company Information Table 74. Zoetis Business Overview Table 75. Zoetis Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio Table 77. Zoetis Recent Development Table 78. Virbac Company Information Table 79. Virbac Business Overview Table 80. Virbac Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio Table 82. Virbac Recent Development Table 83. Vet's Best Company Information Table 84. Vet's Best Business Overview Table 85. Vet's Best Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio Table 87. Vet's Best Recent Development Table 88. Vetoquinol Company Information Table 89. Vetoquinol Business Overview Table 90. Vetoquinol Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio Table 92. Vetoquinol Recent Development Table 93. Sentry Company Information Table 94. Sentry Business Overview Table 95. Sentry Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio Table 97. Sentry Recent Development Table 98. Purdue Pharma L.P. Company Information Table 99. Purdue Pharma L.P. Business Overview Table 100. Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio Table 102. Purdue Pharma L.P. Recent Development Table 103. PetIQ Company Information Table 104. PetIQ Business Overview Table 105. PetIQ Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio Table 107. PetIQ Recent Development Table 108. Perrigo Company Information Table 109. Perrigo Business Overview Table 110. Perrigo Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio Table 112. Perrigo Recent Development Table 113. Nutramax Laboratories Company Information Table 114. Nutramax Laboratories Business Overview Table 115. Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio Table 117. Nutramax Laboratories Recent Development Table 118. Mobedco-Vet Company Information Table 119. Mobedco-Vet Business Overview Table 120. Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio Table 122. Mobedco-Vet Recent Development Table 123. Ceva Santé Animale Company Information Table 124. Ceva Santé Animale Business Overview Table 125. Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio Table 127. Ceva Santé Animale Recent Development Table 128. Boehringer Ingelheim Company Information Table 129. Boehringer Ingelheim Business Overview Table 130. Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio Table 132. Boehringer Ingelheim Recent Development Table 133. Antelope Pets Company Information Table 134. Antelope Pets Business Overview Table 135. Antelope Pets Over-The-Counter (OTC) Pet Medication Sales (Kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio Table 137. Antelope Pets Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Over-The-Counter (OTC) Pet Medication Distributors List Table 141. Over-The-Counter (OTC) Pet Medication Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Over-The-Counter (OTC) Pet Medication Product Image Figure 2. Global Over-The-Counter (OTC) Pet Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over-The-Counter (OTC) Pet Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Over-The-Counter (OTC) Pet Medication Sales (2021-2032) & (Kg) Figure 5. Global Over-The-Counter (OTC) Pet Medication Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Over-The-Counter (OTC) Pet Medication Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Dogs Image Figure 9. Cats Image Figure 10. Others Image Figure 11. Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Over-The-Counter (OTC) Pet Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2021-2032) Figure 14. Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2021-2032) Figure 17. Online Sales Image Figure 18. Offline Sales Image Figure 19. Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 20. Global Over-The-Counter (OTC) Pet Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2021-2032) Figure 22. Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2021-2032) Figure 25. North America Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 26. North America Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 27. U.S. Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 28. Canada Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Mexico Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Europe Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 32. Germany Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 33. France Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 34. U.K. Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Italy Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Netherlands Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 39. China Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Japan Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 41. South Korea Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 42. Southeast Asia Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 43. India Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 44. Australia Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 47. Brazil Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 48. South Africa Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 49. Saudi Arabia Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Turkey Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Argentina Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 52. UAE Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Egypt Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Chile Over-The-Counter (OTC) Pet Medication Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Global Over-The-Counter (OTC) Pet Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Over-The-Counter (OTC) Pet Medication Revenue (2021-2032) & (US$ Million) Figure 58. North America Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Over-The-Counter (OTC) Pet Medication Revenue (2021-2032) & (US$ Million) Figure 60. Europe Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Over-The-Counter (OTC) Pet Medication Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Over-The-Counter (OTC) Pet Medication Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Over-The-Counter (OTC) Pet Medication Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Dogs
  • Cats
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Merck Animal Health
  • Elanco
  • Zoetis
  • Virbac
  • Vet's Best
  • Vetoquinol
  • Sentry
  • Purdue Pharma L.P.
  • PetIQ
  • Perrigo
  • Nutramax Laboratories
  • Mobedco-Vet
  • Ceva Santé Animale
  • Boehringer Ingelheim
  • Antelope Pets

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Over-The-Counter (OTC) Pet Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Over-The-Counter (OTC) Pet Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Over-The-Counter (OTC) Pet Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Over-The-Counter (OTC) Pet Medication Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Over-The-Counter (OTC) Pet Medication Market Dynamics
  1. 2.1 Over-The-Counter (OTC) Pet Medication Industry Trends
  2. 2.2 Over-The-Counter (OTC) Pet Medication Industry Drivers
  3. 2.3 Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges
  4. 2.4 Over-The-Counter (OTC) Pet Medication Industry Restraints
3 Over-The-Counter (OTC) Pet Medication Market by Manufacturers
  1. 3.1 Global Over-The-Counter (OTC) Pet Medication Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Over-The-Counter (OTC) Pet Medication Sales by Manufacturers (2021-2026)
  3. 3.3 Global Over-The-Counter (OTC) Pet Medication Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Over-The-Counter (OTC) Pet Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Over-The-Counter (OTC) Pet Medication Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Over-The-Counter (OTC) Pet Medication Manufacturers, Product Type & Application
  7. 3.7 Global Over-The-Counter (OTC) Pet Medication Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Over-The-Counter (OTC) Pet Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Over-The-Counter (OTC) Pet Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Over-The-Counter (OTC) Pet Medication Tier 1, Tier 2, and Tier 3
4 Over-The-Counter (OTC) Pet Medication Market by Type
  1. 4.1 Over-The-Counter (OTC) Pet Medication Type Introduction
  2. 4.1.1 Dogs
  3. 4.1.2 Cats
  4. 4.1.3 Others
  5. 4.2 Global Over-The-Counter (OTC) Pet Medication Sales by Type
  6. 4.2.1 Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021-2032)
  8. 4.2.3 Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2021-2032)
  9. 4.3 Global Over-The-Counter (OTC) Pet Medication Revenue by Type
  10. 4.3.1 Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2021-2032)
  12. 4.3.3 Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2021-2032)
5 Over-The-Counter (OTC) Pet Medication Market by Application
  1. 5.1 Over-The-Counter (OTC) Pet Medication Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Over-The-Counter (OTC) Pet Medication Sales by Application
  5. 5.2.1 Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021-2032)
  7. 5.2.3 Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2021-2032)
  8. 5.3 Global Over-The-Counter (OTC) Pet Medication Revenue by Application
  9. 5.3.1 Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2021-2032)
  11. 5.3.3 Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2021-2032)
6 Global Over-The-Counter (OTC) Pet Medication Sales by Region
  1. 6.1 Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Over-The-Counter (OTC) Pet Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Over-The-Counter (OTC) Pet Medication Sales by Region (2021-2026)
  4. 6.2.2 Global Over-The-Counter (OTC) Pet Medication Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Over-The-Counter (OTC) Pet Medication Revenue by Region
  1. 7.1 Global Over-The-Counter (OTC) Pet Medication Revenue by Region
  2. 7.1.1 Global Over-The-Counter (OTC) Pet Medication Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Over-The-Counter (OTC) Pet Medication Revenue by Region (2021-2026)
  4. 7.1.3 Global Over-The-Counter (OTC) Pet Medication Revenue by Region (2027-2032)
  5. 7.1.4 Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Over-The-Counter (OTC) Pet Medication Revenue (2021-2032)
  8. 7.2.2 North America Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Over-The-Counter (OTC) Pet Medication Revenue (2021-2032)
  11. 7.3.2 Europe Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Over-The-Counter (OTC) Pet Medication Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Animal Health
  2. 8.1.1 Merck Animal Health Company Information
  3. 8.1.2 Merck Animal Health Business Overview
  4. 8.1.3 Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio
  6. 8.1.5 Merck Animal Health Recent Developments
  7. 8.2 Elanco
  8. 8.2.1 Elanco Company Information
  9. 8.2.2 Elanco Business Overview
  10. 8.2.3 Elanco Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio
  12. 8.2.5 Elanco Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vet's Best
  26. 8.5.1 Vet's Best Company Information
  27. 8.5.2 Vet's Best Business Overview
  28. 8.5.3 Vet's Best Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio
  30. 8.5.5 Vet's Best Recent Developments
  31. 8.6 Vetoquinol
  32. 8.6.1 Vetoquinol Company Information
  33. 8.6.2 Vetoquinol Business Overview
  34. 8.6.3 Vetoquinol Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio
  36. 8.6.5 Vetoquinol Recent Developments
  37. 8.7 Sentry
  38. 8.7.1 Sentry Company Information
  39. 8.7.2 Sentry Business Overview
  40. 8.7.3 Sentry Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio
  42. 8.7.5 Sentry Recent Developments
  43. 8.8 Purdue Pharma L.P.
  44. 8.8.1 Purdue Pharma L.P. Company Information
  45. 8.8.2 Purdue Pharma L.P. Business Overview
  46. 8.8.3 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio
  48. 8.8.5 Purdue Pharma L.P. Recent Developments
  49. 8.9 PetIQ
  50. 8.9.1 PetIQ Company Information
  51. 8.9.2 PetIQ Business Overview
  52. 8.9.3 PetIQ Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio
  54. 8.9.5 PetIQ Recent Developments
  55. 8.10 Perrigo
  56. 8.10.1 Perrigo Company Information
  57. 8.10.2 Perrigo Business Overview
  58. 8.10.3 Perrigo Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio
  60. 8.10.5 Perrigo Recent Developments
  61. 8.11 Nutramax Laboratories
  62. 8.11.1 Nutramax Laboratories Company Information
  63. 8.11.2 Nutramax Laboratories Business Overview
  64. 8.11.3 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio
  66. 8.11.5 Nutramax Laboratories Recent Developments
  67. 8.12 Mobedco-Vet
  68. 8.12.1 Mobedco-Vet Company Information
  69. 8.12.2 Mobedco-Vet Business Overview
  70. 8.12.3 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio
  72. 8.12.5 Mobedco-Vet Recent Developments
  73. 8.13 Ceva Santé Animale
  74. 8.13.1 Ceva Santé Animale Company Information
  75. 8.13.2 Ceva Santé Animale Business Overview
  76. 8.13.3 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio
  78. 8.13.5 Ceva Santé Animale Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
  85. 8.15 Antelope Pets
  86. 8.15.1 Antelope Pets Company Information
  87. 8.15.2 Antelope Pets Business Overview
  88. 8.15.3 Antelope Pets Over-The-Counter (OTC) Pet Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio
  90. 8.15.5 Antelope Pets Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Over-The-Counter (OTC) Pet Medication Value Chain Analysis
  2. 9.1.1 Over-The-Counter (OTC) Pet Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Over-The-Counter (OTC) Pet Medication Production Mode & Process
  6. 9.2 Over-The-Counter (OTC) Pet Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Over-The-Counter (OTC) Pet Medication Distributors
  9. 9.2.3 Over-The-Counter (OTC) Pet Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research